Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Risa Kagan

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Menopause (New York, N.Y.)|May 1, 2012
Surgical menopause: still confused after all these yearsRisa Kagan
Menopause (New York, N.Y.)|October 28, 2024
Symptoms of menopauseRisa Kagan
Journal of Women'S Health (2002)|July 5, 2012
The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptomsRisa Kagan
Menopause (New York, N.Y.)|September 20, 2017
Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopauseRisa Kagan, Eliza Rivera
Expert Opinion on Pharmacotherapy|December 5, 2015
Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical useJoAnn V Pinkerton, Risa Kagan
Postgraduate Medicine|October 4, 2018
Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placeboRisa Kagan, Paula Abreu, Emma Andrews
Cleveland Clinic Journal of Medicine|November 9, 2016
In Reply: Menopausal hormone therapyLaura Dorr Lipold, Pelin Batur, Risa Kagan
Cleveland Clinic Journal of Medicine|August 10, 2016
Is there a time limit for systemic menopausal hormone therapy?Laura Dorr Lipold, Pelin Batur, Risa Kagan
Clinical Obstetrics and Gynecology|September 12, 2013
Controversies in osteoporosis management: how do you treat a newly menopausal woman with low bone mass: when and how is it appropriate to provide pharmacologic intervention to prevent osteoporosis?Xuezhi Jiang, Risa Kagan, Peter F Schnatz
Drugs & Aging|August 28, 2019
Practical Treatment Considerations in the Management of Genitourinary Syndrome of MenopauseRisa Kagan, Susan Kellogg-Spadt, Sharon J Parish
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Menopause (New York, N.Y.)|May 1, 2012
Surgical menopause: still confused after all these yearsRisa Kagan
Menopause (New York, N.Y.)|October 28, 2024
Symptoms of menopauseRisa Kagan
Journal of Women'S Health (2002)|July 5, 2012
The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptomsRisa Kagan
Menopause (New York, N.Y.)|September 20, 2017
Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopauseRisa Kagan, Eliza Rivera
Expert Opinion on Pharmacotherapy|December 5, 2015
Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical useJoAnn V Pinkerton, Risa Kagan
Postgraduate Medicine|October 4, 2018
Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placeboRisa Kagan, Paula Abreu, Emma Andrews
Cleveland Clinic Journal of Medicine|November 9, 2016
In Reply: Menopausal hormone therapyLaura Dorr Lipold, Pelin Batur, Risa Kagan
Cleveland Clinic Journal of Medicine|August 10, 2016
Is there a time limit for systemic menopausal hormone therapy?Laura Dorr Lipold, Pelin Batur, Risa Kagan
Clinical Obstetrics and Gynecology|September 12, 2013
Controversies in osteoporosis management: how do you treat a newly menopausal woman with low bone mass: when and how is it appropriate to provide pharmacologic intervention to prevent osteoporosis?Xuezhi Jiang, Risa Kagan, Peter F Schnatz
Drugs & Aging|August 28, 2019
Practical Treatment Considerations in the Management of Genitourinary Syndrome of MenopauseRisa Kagan, Susan Kellogg-Spadt, Sharon J Parish
Pageof 5